Q3  2024 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 7.88% |
14,267 |
0.33 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 25.89% |
30,612 |
0.53 |
≡ |
Greenhaven Associates |
Reduce 33.33% |
2,500 |
0.01 |
Q2  2024 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.73% |
3,187 |
0.08 |
≡ |
Torray Funds |
Reduce 8.61% |
7,971 |
0.24 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 12.72% |
217,659 |
0.47 |
≡ |
Kahn Brothers Group |
Reduce 13.19% |
510 |
0.02 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 28.03% |
60,745 |
0.65 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 42.70% |
1,378,316 |
1.58 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 45.24% |
97,687 |
1.71 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 99.57% |
1,292,985 |
6.87 |
≡ |
Greenhaven Associates |
Reduce 99.84% |
4,618,884 |
12.32 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,263 |
0.01 |
Q1  2024 |
≡ |
Greenhaven Associates |
Reduce 2.06% |
97,120 |
0.18 |
≡ |
Torray Funds |
Reduce 9.11% |
9,273 |
0.28 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 11.51% |
23,973 |
0.57 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 15.46% |
312,875 |
0.64 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 19.17% |
765,565 |
0.86 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 19.26% |
51,687 |
0.50 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 21.59% |
357,530 |
1.50 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 21.92% |
60,611 |
0.72 |
≡ |
Kahn Brothers Group |
Reduce 33.03% |
1,907 |
0.05 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 36.70% |
1,312 |
0.01 |
Q4  2023 |
≡ |
Kahn Brothers Group |
Reduce 0.02% |
1 |
0.00 |
≡ |
Torray Funds |
Reduce 0.33% |
339 |
0.01 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.44% |
7,382 |
0.03 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 2.10% |
4,460 |
0.10 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 3.48% |
143,951 |
0.14 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 3.58% |
75,056 |
0.13 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 12.60% |
38,707 |
0.35 |
≡ |
Bill & Melinda Gates Foundation Trust |
Sell 100.00% |
29,600 |
0.01 |
Q3  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.02% |
52 |
0.00 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 0.69% |
14,492 |
0.02 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.16% |
2,488 |
0.05 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 1.43% |
24,178 |
0.09 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.64% |
68,902 |
0.06 |
≡ |
Greenhaven Associates |
Reduce 1.83% |
87,900 |
0.17 |
≡ |
Torray Funds |
Reduce 2.95% |
3,109 |
0.08 |
Q2  2023 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.59% |
10,029 |
0.04 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
269,917 |
2.20 |
Q1  2023 |
≡ |
Torray Funds |
Reduce 0.54% |
570 |
0.01 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.67% |
11,418 |
0.05 |
≡ |
Greenhaven Associates |
Reduce 1.19% |
57,000 |
0.12 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 1.37% |
25,205 |
0.03 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.83% |
4,002 |
0.08 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.89% |
80,885 |
0.07 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 10.99% |
5,000 |
0.29 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 11.39% |
35,548 |
0.31 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 22.70% |
79,264 |
0.65 |
Q4  2022 |
≡ |
Torray Funds |
Reduce 0.09% |
95 |
0.00 |
≡ |
Greenhaven Associates |
Reduce 0.52% |
25,200 |
0.06 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.02% |
2,258 |
0.05 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 1.51% |
26,136 |
0.11 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 3.79% |
168,160 |
0.15 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 4.38% |
84,500 |
0.13 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 10.88% |
42,622 |
0.37 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 17.10% |
64,375 |
0.53 |
≡ |
Francis Chou - Chou Associates |
Sell 100.00% |
24,275 |
2.51 |
Q3  2022 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.14% |
2,489 |
0.01 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 0.41% |
901 |
0.02 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 1.33% |
25,928 |
0.03 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.36% |
61,447 |
0.05 |
≡ |
Kahn Brothers Group |
Reduce 1.77% |
50 |
0.00 |
≡ |
Francois Rochon - Giverny Capital |
Reduce 89.96% |
255,638 |
1.79 |
Q2  2022 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 1.10% |
4,353 |
0.03 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 3.08% |
143,351 |
0.10 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 8.37% |
178,540 |
0.22 |
≡ |
Kahn Brothers Group |
Reduce 10.32% |
325 |
0.00 |
≡ |
Viking Global Investors |
Sell 100.00% |
119,706 |
0.07 |
Q1  2022 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 2.72% |
11,019 |
0.06 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 4.56% |
221,928 |
0.15 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 9.01% |
211,225 |
0.28 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 9.52% |
3,800 |
0.20 |
≡ |
Torray Funds |
Reduce 17.29% |
18,772 |
0.41 |
≡ |
Francis Chou - Chou Associates |
Reduce 29.18% |
10,000 |
1.01 |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
Sell 100.00% |
75,000 |
1.16 |
Q4  2021 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 2.24% |
111,582 |
0.08 |
≡ |
Torray Funds |
Reduce 5.24% |
6,003 |
0.14 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 6.80% |
171,152 |
0.24 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 10.34% |
46,754 |
0.26 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 10.59% |
177,133 |
0.89 |
≡ |
Kahn Brothers Group |
Reduce 10.64% |
375 |
0.01 |
≡ |
Francois Rochon - Giverny Capital |
Reduce 29.99% |
114,483 |
0.97 |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
Reduce 46.43% |
65,000 |
1.01 |
Q3  2021 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 0.48% |
2,163 |
0.01 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 9.48% |
175,212 |
1.00 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 9.78% |
272,731 |
0.41 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 12.70% |
724,732 |
0.55 |
Q2  2021 |
≡ |
Torray Funds |
Reduce 0.06% |
74 |
0.00 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 0.79% |
1,707 |
0.04 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Reduce 9.47% |
291,655 |
0.38 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 10.30% |
655,327 |
0.42 |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
Reduce 13.85% |
22,500 |
0.37 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 15.35% |
334,876 |
1.79 |
≡ |
Viking Global Investors |
Sell 100.00% |
874,417 |
0.40 |
≡ |
Dodge & Cox |
Sell 100.00% |
151,200 |
0.03 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
4,453 |
0.01 |
Q1  2021 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 0.09% |
384 |
0.00 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 0.48% |
1,385 |
0.01 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 2.08% |
46,309 |
0.23 |